Author： Najafian N. Sayegh M.H.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.9, 2000-09, pp. : 2147-2157
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mechanisms of CTLA-4-Ig in Tolerance Induction
Current Pharmaceutical Design, Vol. 12, Iss. 2, 2006-01 ,pp. :
Access to resources
Recommend
CTLA4-Ig promising in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. :
CTLA4-Ig: First report of drug eruption: case report
Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. :
Engineering high avidity CTLA4Ig for therapy of rheumatic diseases
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 9, 2002-09 ,pp. :